Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin

STAT3 Regulates the Onset of Oxidant-Induced Senescence in Lung Fibroblasts

(2019) David W Waters et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Growth hormone-releasing hormone receptor mediates cytokine production in ciliary and iris epithelial cells during LPS-induced ocular inflammation

(2019) Jia Lin Ren et al.   EXPERIMENTAL EYE RESEARCH

Extracellular matrix as a driver of progressive fibrosis

(2018) Jeremy Herrera et al.   JOURNAL OF CLINICAL INVESTIGATION

Idiopathic Pulmonary Fibrosis

(2018) David J. Lederer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular characterization of a precision-cut rat lung slice model for the evaluation of antifibrotic drugs

(2018) Xinqiang Huang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis

(2017) Ying Wei et al.   JOURNAL OF CLINICAL INVESTIGATION

Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth

(2017) Marta Zarandi et al.   PEPTIDES

Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores

(2017) Palak G. Patel et al.   PLoS One

Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer

(2017) Medhi Wangpaichitr et al.   Oncotarget

PI3K/Akt signaling is involved in the pathogenesis of bleomycin-induced pulmonary fibrosis via regulation of epithelial-mesenchymal transition

(2016) Xiao-Ling Zhang et al.   Molecular Medicine Reports

Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1–STAT3/NF-κB signaling

(2016) Jinfeng Gan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

OX40L blockade protects against inflammation-driven fibrosis

(2016) Muriel Elhai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways

(2016) Julia Barbara Kral et al.   Scientific Reports

Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume

(2015) Greetje Vande Velde et al.   Disease Models & Mechanisms

Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers

(2015) Roberto Perez et al.   Oncotarget

Gene expression profiles reveal molecular mechanisms involved in the progression and resolution of bleomycin-induced lung fibrosis

(2013) Sandra Cabrera et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

(2013) Edward Y Chen et al.   BMC BIOINFORMATICS

Role of IGF-1 pathway in lung fibroblast activation

(2013) Chi F Hung et al.   RESPIRATORY RESEARCH

STAR: ultrafast universal RNA-seq aligner

(2012) Alexander Dobin et al.   BIOINFORMATICS

Growth hormone-releasing hormone: not only a neurohormone

(2011) Hippokratis Kiaris et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Standardized quantification of pulmonary fibrosis in histological samples

(2008) Ralf-Harto Hübner et al.   BIOTECHNIQUES

Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line

(2008) N. Barabutis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

(2007) Andrew V Schally et al.   Nature clinical practice. Endocrinology & metabolism